Corvus Pharmaceuticals, Inc. (CRVS) is currently at $4.24, up $0.89 or 26.57%
--Would be highest close since March 24, 2025, when it closed at $4.25
--On pace for largest percent increase since May 17, 2023, when it rose 36.71%
--Currently up two consecutive days; up 32.5% over this period
--Best two day stretch since the two days ending May 18, 2023, when it rose 37.13%
--Up 18.11% month-to-date
--Down 20.75% year-to-date
--Down 80.16% from its all-time closing high of $21.37 on March 27, 2017
--Up 103.85% from 52 weeks ago (May 10, 2024), when it closed at $2.08
--Down 55.65% from its 52-week closing high of $9.56 on Nov. 11, 2024
--Up 138.2% from its 52-week closing low of $1.78 on July 3, 2024
--Traded as high as $4.38; highest intraday level since March 25, 2025, when it hit $4.38
--Up 30.74% at today's intraday high; largest intraday percent increase since May 17, 2023, when it rose as much as 38.82%
All data as of 11:26:31 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 09, 2025 11:30 ET (15:30 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。